Hematology: ESAs to treat anemia--balancing the risks and benefits

Affiliations

John Glaspy. Nat Rev Clin Oncol. 2009 Sep.

. 2009 Sep;6(9):500-2.

doi: 10.1038/nrclinonc.2009.126.

¹ University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095-6956, USA. jglaspy@mednet.ucla.edu

No abstract available

Cited by

Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.
He L, Wu S, Hao Q, Dioum EM, Zhang K, Zhang C, Li W, Zhang W, Zhang Y, Zhou J, Pang Z, Zhao L, Ma X, Li M, Zhang Q. He L, et al. Oncotarget. 2017 Jul 18;8(47):82352-82365. doi: 10.18632/oncotarget.19354. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137269 Free PMC article.
AMPKα1 deletion in fibroblasts promotes tumorigenesis in athymic nude mice by p52-mediated elevation of erythropoietin and CDK2.
Zhou Y, Xu H, Ding Y, Lu Q, Zou MH, Song P. Zhou Y, et al. Oncotarget. 2016 Aug 16;7(33):53654-53667. doi: 10.18632/oncotarget.10687. Oncotarget. 2016. PMID: 27449088 Free PMC article.
Erythropoietin Stimulates Tumor Growth via EphB4.
Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, Nagaraja AS, Previs RA, Vivas-Mejia P, Han HD, Hu W, Mangala LS, Zand B, Stagg LJ, Ladbury JE, Ozpolat B, Alpay SN, Nishimura M, Stone RL, Matsuo K, Armaiz-Peña GN, Dalton HJ, Danes C, Goodman B, Rodriguez-Aguayo C, Kruger C, Schneider A, Haghpeykar S, Jaladurgam P, Hung MC, Coleman RL, Liu J, Li C, Urbauer D, Lopez-Berestein G, Jackson DB, Sood AK. Pradeep S, et al. Cancer Cell. 2015 Nov 9;28(5):610-622. doi: 10.1016/j.ccell.2015.09.008. Epub 2015 Oct 17. Cancer Cell. 2015. PMID: 26481148 Free PMC article.